逆流检测产品市场 - 全球产业规模、份额、趋势、机会和预测，按产品类型、疾病适应症、最终用户、地区和竞争细分，2020-2030 年预测

2024 年全球逆流检测产品市场价值为 36.5 亿美元，预计到 2030 年将达到 49.1 亿美元，预测期内复合年增长率为 5.02%。全球反流检测产品市场是更广泛的医疗保健产业中一个充满活力且快速发展的产业。逆流检测产品是医疗专业人员用来诊断和治疗胃食道逆流症 (GERD) 及其他相关疾病的重要工具。该市场涵盖广泛的诊断设备和消耗品，包括 pH 监测系统、阻抗-pH 监测系统、食道测压设备和相关配件。

全球逆流检测产品市场成长的主要驱动力之一是全球 GERD 及其相关疾病的盛行率不断上升。不健康的生活方式、肥胖和饮食习惯等因素导致胃酸倒流发病率上升，从而推动了对准确诊断工具的需求。人口老化容易引发食道疾病，进一步推动了市场的扩张。

技术进步在塑造反流检测产品格局方面发挥了关键作用。感测器技术、无线连接和资料分析的创新提高了诊断程序的精确度和便利性，从而改善了患者的治疗效果和诊断的准确性。向微创诊断技术的转变推动了先进反流检测产品的采用，为患者提供了侵入性更小、更舒适的体验。近年来，人们越来越重视开发以患者为中心的诊断解决方案，包括家庭逆流检测试剂盒，预计将为市场创造新的机会。此外，医疗器材製造商和医疗保健提供者之间的合作可能会透过确保反流检测产品的可近性和可负担性来推动市场成长。

主要市场驱动因素

胃食道逆流症（GERD）盛行率上升

主要市场挑战

成本限制

主要市场趋势

转向微创技术

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球逆流检测产品市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品类型（导管检测产品、胶囊检测产品、逆流检测探头、其他）
  • 依疾病指征（巴雷特食道、逆流性食道炎、食道腺癌）
  • 按最终使用者（医院和诊所、门诊手术中心、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第 6 章：北美逆流检测产品市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 加拿大
  • 墨西哥

第 7 章：欧洲逆流检测产品市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区逆流检测产品市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲逆流检测产品市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲逆流检测产品市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如果有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Medtronic Plc
• Sierra Instruments, Inc.
• Respiratory Technology Corporation
• Ethicon, Inc.
• Medical Measurement Systems BV
• AstraZeneca Plc
• Diversatek, Inc.
• FLSmidth A/S
• Laborie Medical Technologies Corp.
• DRG Instruments GmbH

第 15 章：策略建议

第16章 调査会社について・免责事项

Global Reflux Testing Products Market was valued at USD 3.65 Billion in 2024 and is expected to reach USD 4.91 Billion by 2030 with a CAGR of 5.02% during the forecast period. The Global Reflux Testing Products Market is a dynamic and rapidly evolving sector within the broader healthcare industry. Reflux testing products are essential tools used by medical professionals to diagnose and manage gastroesophageal reflux disease (GERD) and other related conditions. This market encompasses a wide range of diagnostic devices and consumables, including pH monitoring systems, impedance-pH monitoring systems, esophageal manometry equipment, and associated accessories.

One of the key drivers of growth in the Global Reflux Testing Products Market is the increasing prevalence of GERD and related disorders worldwide. Factors such as unhealthy lifestyles, obesity, and dietary habits have contributed to a rising incidence of acid reflux, thereby fuelling the demand for accurate diagnostic tools. The aging population is prone to esophageal disorders, further boosting the market's expansion.

Technological advancements have played a pivotal role in shaping the landscape of reflux testing products. Innovations in sensor technology, wireless connectivity, and data analysis have enhanced the precision and convenience of diagnostic procedures, leading to improved patient outcomes and diagnostic accuracy. The shift towards minimally invasive diagnostic techniques has driven the adoption of advanced reflux testing products, offering patients a less invasive and more comfortable experience. In recent years, there has been a growing emphasis on the development of patient-centric diagnostic solutions, including home-based reflux testing kits, which are expected to create new opportunities in the market. Moreover, collaborations between medical device manufacturers and healthcare providers are likely to drive market growth by ensuring accessibility and affordability of reflux testing products.

Key Market Drivers

Rising Prevalence of gastroesophageal reflux disease (GERD)

The rising prevalence of gastroesophageal reflux disease (GERD) is a significant driver behind the growth of the Global Reflux Testing Products Market. GERD is a chronic digestive disorder characterized by the frequent and recurrent flow of stomach acid into the esophagus, leading to uncomfortable symptoms like heartburn, regurgitation, and chest pain. This condition has become increasingly common in recent years, affecting millions of individuals worldwide.

Several factors contribute to the escalating prevalence of GERD. Unhealthy dietary habits, including the consumption of high-fat, spicy, and acidic foods, as well as excessive alcohol and caffeine intake, have been linked to the development of GERD. Furthermore, the global rise in obesity rates has added to the burden of GERD, as excess body weight can increase abdominal pressure, pushing stomach contents into the esophagus. According to Journal of Neurogastroenterology and Motility , GERD is a chronic and widespread condition. A recent systematic review found its prevalence to range from 18.1% to 27.8% in North America, 8.8% to 25.9% in Europe, 2.5% to 7.8% in East Asia, 8.7% to 33.1% in the Middle East, 11.6% in Australia, and 23.0% in South America. The rising prevalence of GERD can be attributed to various factors, including older age, male gender, ethnicity, the use of analgesics, consumption of specific foods and beverages, a decrease in Helicobacter pylori infection rates, smoking, family history, high body mass index (BMI), and low physical activity levels. Many of these risk factors are closely tied to lifestyle choices.

Sedentary lifestyles and prolonged periods of sitting, often associated with modern working environments, can also contribute to GERD. Individuals spending long hours at desks or in front of screens may be more prone to experiencing acid reflux symptoms. As awareness of GERD and its potential complications has grown, more individuals are seeking medical attention and diagnosis. This surge in patient visits to healthcare professionals has driven the demand for reflux testing products. Accurate diagnosis is essential for proper management, as GERD can lead to serious complications, including Barrett's esophagus and esophageal cancer if left untreated.

In response to the increasing prevalence of GERD, the Global Reflux Testing Products Market has expanded to provide innovative and advanced diagnostic tools. These tools include pH monitoring systems, impedance-pH monitoring systems, and other cutting-edge devices designed to precisely assess and diagnose GERD. Additionally, the market has seen the development of patient-friendly, minimally invasive testing options, which encourage individuals to seek diagnosis and treatment.

Key Market Challenges

Cost Constraints

One of the primary factors contributing to cost constraints in the reflux testing products market is the high manufacturing costs associated with advanced diagnostic tools. Devices such as pH monitoring systems and impedance-pH monitoring systems are technologically sophisticated, requiring precision engineering and high-quality materials. The intricate sensors, data processing components, and wireless connectivity capabilities all contribute to elevated manufacturing expenses.

Apart from initial manufacturing costs, the maintenance and calibration of reflux testing products can be expensive. These devices must undergo regular servicing and calibration to ensure their accuracy. Healthcare facilities that offer reflux testing services are burdened with the recurring cost of maintaining and updating their equipment, which, in turn, can lead to higher prices for patients.

The availability of comprehensive insurance coverage for reflux testing procedures varies widely across regions and healthcare plans. Many insurance providers do not fully cover the costs of reflux testing, leaving patients to bear a substantial portion of the financial burden. This lack of adequate insurance coverage can discourage individuals from pursuing reflux testing, particularly those with limited financial resources.

The cost constraints in the reflux testing products market have implications for the accessibility and affordability of these diagnostic tools. In regions with limited healthcare resources, including lower- and middle-income countries, the high cost of reflux testing products can significantly limit their availability. As a result, individuals in these areas may not have access to essential diagnostic services.

Key Market Trends

Shift Towards Minimally Invasive Techniques

The Global Reflux Testing Products Market has witnessed a significant boost due to the ongoing trend towards minimally invasive diagnostic techniques. Traditional methods for diagnosing gastroesophageal reflux disease (GERD), such as invasive endoscopy and barium swallow studies, often involve uncomfortable and invasive procedures that can discourage patients from seeking diagnosis and treatment. This has led to a growing preference among both healthcare providers and patients for less invasive and more patient-friendly alternatives, thereby fuelling the demand for reflux testing products.

Minimally invasive reflux testing products, such as wireless pH monitoring systems and impedance-pH monitoring systems, have become increasingly popular due to their ability to provide accurate diagnostic data without the need for intrusive procedures. These devices offer patients a more comfortable experience, as they can be worn for extended periods without interfering with daily activities. This patient-centric approach not only enhances patient acceptance but also encourages individuals to seek timely diagnosis and treatment for their GERD symptoms. In June 2022, Glenmark Pharmaceuticals Ltd completed the acquisition of approved generic versions of select over-the-counter medications from Wockhardt Ltd in the United States. This acquisition was executed through Glenmark Pharmaceuticals Inc., USA, a wholly owned subsidiary of the company. The acquired assets encompass approved abbreviated new drug applications (ANDAs), including famotidine tablets (10 mg and 20 mg), which are utilized for the treatment and prevention of stomach and intestinal ulcers, indigestion, heartburn, as well as Lansoprazole delayed-release capsules USP, 15 mg, among other pharmaceutical products.

Key Market Players

• Medtronic Plc
• Sierra Instruments, Inc.
• Respiratory Technology Corporation
• Ethicon, Inc.
• Medical Measurement Systems BV
• AstraZeneca Plc
• Diversatek, Inc.
• FLSmidth A/S
• Laborie Medical Technologies Corp.
• DRG Instruments GmbH

Report Scope:

In this report, the Global Reflux Testing Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Reflux Testing Products Market, By Product Type:

• Catheter Based Testing Products
• Capsule Based Testing Products
• Reflux Testing Probes
• Other

Reflux Testing Products Market, By Disease Indication:

• Barrett's Esophagus
• Reflux Esophagitis
• Esophageal Adenocarcinoma

Reflux Testing Products Market, By End User:

• Hospitals &Clinics
• Ambulatory Surgical Centers
• Other

Global Reflux Testing Products Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Reflux Testing Products Market.

Available Customizations:

Global Reflux Testing Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Reflux Testing Products Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Catheter Based Testing Products, Capsule Based Testing Products, Reflux Testing Probes, Others)
  • 5.2.2. By Disease Indication (Barrett's Esophagus, Reflux Esophagitis, Esophageal Adenocarcinoma)
  • 5.2.3. By End User (Hospitals &Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Reflux Testing Products Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Disease Indication
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Reflux Testing Products Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Disease Indication
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Reflux Testing Products Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Disease Indication
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Reflux Testing Products Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Disease Indication
      • 6.3.3.2.3. By End User

7. Europe Reflux Testing Products Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Disease Indication
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Reflux Testing Products Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Disease Indication
      • 7.3.1.2.3. By End User
  • 7.3.2. United Kingdom Reflux Testing Products Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Disease Indication
      • 7.3.2.2.3. By End User
  • 7.3.3. Italy Reflux Testing Products Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Disease Indication
      • 7.3.3.2.3. By End User
  • 7.3.4. France Reflux Testing Products Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Disease Indication
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Reflux Testing Products Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Disease Indication
      • 7.3.5.2.3. By End User

8. Asia-Pacific Reflux Testing Products Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Disease Indication
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Reflux Testing Products Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Disease Indication
      • 8.3.1.2.3. By End User
  • 8.3.2. India Reflux Testing Products Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Disease Indication
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Reflux Testing Products Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Disease Indication
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Reflux Testing Products Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Disease Indication
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Reflux Testing Products Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Disease Indication
      • 8.3.5.2.3. By End User

9. South America Reflux Testing Products Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Disease Indication
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Reflux Testing Products Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Disease Indication
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Reflux Testing Products Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Disease Indication
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Reflux Testing Products Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Disease Indication
      • 9.3.3.2.3. By End User

10. Middle East and Africa Reflux Testing Products Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Disease Indication
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Reflux Testing Products Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Disease Indication
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Reflux Testing Products Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Disease Indication
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Reflux Testing Products Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Disease Indication
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Medtronic Plc
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Sierra Instruments, Inc.
• 14.3. Respiratory Technology Corporation
• 14.4. Ethicon, Inc.
• 14.5. Medical Measurement Systems BV
• 14.6. AstraZeneca Plc
• 14.7. Diversatek, Inc.
• 14.8. FLSmidth A/S
• 14.9. Laborie Medical Technologies Corp.
• 14.10. DRG Instruments GmbH

15. Strategic Recommendations

16. About Us & Disclaimer